Metabolomics is one of the newer omics fields, and has enabled researchers to complement
genomic and protein level analysis of disease with both semi-quantitative and quantitative …

Determining metabolomic differences among samples of different phenotypes is a critical
component of metabolomics research. With the rapid advances in analytical tools such as …

Background & Aims The incidence of inflammatory bowel diseases has increased over the
last half century, suggesting a role for dietary factors. Fructose consumption has increased in …

With the growth of metabolomics research, more and more studies are conducted on large
numbers of samples. Due to technical limitations of the Liquid Chromatography–Mass …

Improving the quantitative performance of mass spectrometry (MS)-based metabolomics is
the key to its successful application in a broad range of research questions. Like other …

Despite the attractiveness of breath analysis as a non-invasive means to retrieve relevant
metabolic information, its introduction into routine clinical practice remains a challenge …

Mass spectrometry (MS) has become an indispensable tool for metabolomics studies.
However, due to the lack of applicable experimental platforms, suitable algorithm, software …

The scale at which MS‐and NMR‐based platforms generate metabolomics datasets for both
research, core, and clinical facilities to address challenges in the various sciences—ranging …

Background Tuberculosis (TB) is the leading infectious cause of death worldwide. A major
barrier to control of the pandemic is a lack of clinical biomarkers with the ability to distinguish …

Adverse reactions to foods and adverse drug reactions are inherent in product defects,
medication errors, and differences in individual drug exposure. Pharmacogenetics is the …